Variant report
Variant | nsv967248 |
---|---|
Chromosome Location | chr3:19668793-19673736 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142445178 | chr3:19672408-19672409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554406352 | chr3:19672425-19672426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189847003 | chr3:19672470-19672471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543278206 | chr3:19672500-19672501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558805885 | chr3:19672516-19672517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6787710 | chr3:19672573-19672574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs541338377 | chr3:19672612-19672613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112890017 | chr3:19672649-19672650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559684604 | chr3:19672675-19672676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530081597 | chr3:19672723-19672724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542192824 | chr3:19672724-19672725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563659186 | chr3:19672766-19672767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531056303 | chr3:19672789-19672790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13071260 | chr3:19672807-19672808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13071268 | chr3:19672821-19672822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552218619 | chr3:19672849-19672850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570719651 | chr3:19672860-19672861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528614180 | chr3:19672862-19672863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181109738 | chr3:19672863-19672864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9857864 | chr3:19672864-19672865 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs535901892 | chr3:19672877-19672878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115971877 | chr3:19672913-19672914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569519756 | chr3:19672928-19672929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs62278787 | chr3:19672936-19672937 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs558642404 | chr3:19672965-19672966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577157678 | chr3:19673082-19673083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145952515 | chr3:19673090-19673091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113454462 | chr3:19673137-19673138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139799957 | chr3:19673189-19673190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574655765 | chr3:19673231-19673232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371221488 | chr3:19673244-19673245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112496875 | chr3:19673293-19673294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115221324 | chr3:19673313-19673314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563718187 | chr3:19673325-19673326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575508447 | chr3:19673378-19673379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545893800 | chr3:19673393-19673394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564237825 | chr3:19673431-19673432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111379906 | chr3:19673482-19673483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528698969 | chr3:19673490-19673491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185645723 | chr3:19673534-19673535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190451512 | chr3:19673550-19673551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550193696 | chr3:19673561-19673562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577072461 | chr3:19673568-19673569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550954911 | chr3:19673617-19673618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569639088 | chr3:19673623-19673624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112244748 | chr3:19673664-19673665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144543063 | chr3:19673677-19673678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545645759 | chr3:19673722-19673723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13324034 | chr3:19673724-19673725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:19672400-19674400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr3:19673600-19674200 | Enhancers | GM12878-XiMat | blood |
3 | chr3:19673600-19674400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr3:19673600-19674800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |